Pregnancy and childbirth in a patient with myelodysplastic syndrome


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. As of now, progress in therapy has frequently made it possible to plan pregnancy and safe childbirth in women with different hematological diseases. Myelodysplastic syndrome (MDS) is a group of severe clonal hematopoietic diseases that are most common in the old age group. Pregnancy in patients with MDS is extremely rare and associated with an increased risk of both maternal and fetal complications. Case report. The paper describes a case of successful pregnancy and childbirth in a 30-year-old patient with partial remission of refractory anemia with excess of blasts. Conclusion. Adequate initial therapy for the underlying disease, planning, and careful interdisciplinary follow-up throughout the gestation has promoted a favorable pregnancy outcome.

Texto integral

Acesso é fechado

Sobre autores

Roman Shmakov

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
M.D., Head Physician

Maria Vinogradova

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: m_vinogradova@oparina4.ru
Ph.D, Head of reproductive hematology and hemostasia department

Evgenia Polushkina

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: epolushkina@mail.ru
Ph.D, Researcher, Obstetrical Physiologic Department

Elena Kozyrko

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: lenochka525@gmail.com
Researcher, Obstetrical Physiologic Department

Bibliografia

  1. Савченко В.Г., ред. Программное лечение заболеваний системы крови. Сборник алгоритмов диагностики и протоколов лечения заболеваний системы крови. М.: Практика; 2012. 1056с. [Savchenko V.G., ed. Software treatment of diseases of the blood system. Collection of diagnostic algorithms and protocols, treatment of diseases of the blood system. Moscow: Praktika; 2012. 1056p. (in Russian)]
  2. Кохно А.В., Паровичникова Е.Н., Савченко В.Г. Миелодиспластический синдром. Клиническая геронтология. 2009; 15(3): 33-46. [Kohno A.V., Parovichnikova E.N., Savchenko V.G. Myelodysplastic syndrome. Klinicheskaya gerontologiya. 2009; 15 (3): 33-46. (in Russian)]
  3. Schanz J., Tüchler H., Solé F., Mallo M., Luno E., Cervera J. et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J. Clin. Oncol. 2012; 30(8): 820-9. doi: 10.1200/ JCO.2011.35.6394.
  4. Al-Ameri A., Cherry M., Garcia-Manero G., Quintás-Cardama A. Standard therapy for patients with myelodysplastic syndromes. Clin. Lymphoma Myeloma Leuk. 2011; 11(4): 303-13. doi: 10.1016/j.clml.2011.06.008.
  5. NCCN Clinical Practice Guidelines in Oncology. Myelodysplastic syndromes v 1.2012. Available at: http://www.nccn.org/professionals/ physician_gls/pdf/ mds.pdf Accessed March 9, 2012.
  6. Yang Z., Mei-Ying L., Shan-Mi W., Xiao-Hui Z. Pregnancy and myelodys-plastic syndrome: an analysis of the clinical characteristics, maternal and fetal outcomes. J. Matern. Fetal Neonatal Med. 2015; 28(18): 2155-9. doi: 10.3109/14767058.2014.980229.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies